Impact of New-onset Insomnia After Coronary Revascularization for Patients With Acute Myocardial Infarction
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSamsung Medical Center
About this trial
The present study aimed to evaluate the impact of acute insomnia on long-term clinical outcomes in patients underwent PCI or CABG for AMI using the Korean National Health Insurance Service (NHIS) database, and to identify the factors through which insomnia contributes to prognostic determination in this patient population.
Eligibility criteria
Qualifiers
Diagnosis of acute myocardial infarction
Undergoing percutaneous coronary intervention or coronary artery bypass surgery
Disqualifiers
Pre-existing phychiatric disorders
Trial design
Treatments tested in this trial
- Insomnia medication
- No insomnia medication
Treatment groups
235,342 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov